Professional Documents
Culture Documents
Bleeding
Dr. Mashael Shebaili
Asst. Prof. & Consultant
Ob/Gyne Department
Normal menstruation
Rhythm:
days
Duration:
Amount:
Flow:
3-7 days
Causes of Menorrhagia
DUB
Pelvic
pathology
Medical
Clotting
defect
Dysfunctional uterine
bleeding
Definition: uterine bleeding in
the absence of an organic
disease
Incidence: 10-20% usually at
extremes of reproductive life.
examination
Abdomino-pelvic
Investigations
examination
(mainly
exclude organic causes)
to
Treatment
I. Medical treatment
A. Non-steroidal anti-inflammatory
drugs
Mechanism of action: inhibit cyclooxygenase enzyme and the
production of prostaglandins
Phospholipids phospholipase A
arachidonic acid cyclo-oxygenase
prostaglandins
2
Possible Pathophysiology
1) Shift
2) Increase
3) Effect
:Effectiveness
1.
2.
Relief dysmenorrhoea
3.
:Side effects
Mainly
mild gastrointestinal
tract irritation
The
B. Antifibrinolytic agents
Mechanism of action:
Prevent
conversion
of
Effectiveness:
Reduce
measured loss by
40-50%. The effect is dose
related. It should be given
with
the
start
of
menstruation and continue
for 3-4 days.
Comparative
studies suggested
than
PG
(Milsom
synthetase
et
al.1991;
Side effects:
1.
Mild
gastrointestinal
irritation
tract
2.
3.
4.
history
embolism.
of
thrombo-
Mechanism of action:
Mainly locally by inducing endometrial
atrophy with reduction in both PG synthesis
and fibrinolysis.
Side effects:
i.
ii.
2.Progestogens
Mechanism of action:
1.
2.
Effectiveness:
1.
2.
Side effects:
Usually minimal as abdominal
bloating and weight gain
Effectiveness:
Scandinavian
study
Danazol:
of
pituitary
gland
that
relief amenorrhoea in
Side effects:
Surgical treatment
Suitable for older patients who have no
further wish to conceive.
I.Endometrial ablation/resection
To remove or destroy the endometrium
producing changes similar to Ashermans
syndrome (Laser electrocautary - roller
ball - diathermy microwave- hot
balloon).
2.
3.
Disadvantages:
1.
Needs experience
2.
3.
4.
II. Hysterectomy
Definitive
cure
for
(Abdominal, vaginal or
(total or subtotal)
menorrhagia
laparoscopic)
Disadvantages:
Mortality of 6/10000 procedures
2. Injury of ureter, bladder or bowel.
1.
POSTMENOPAUSAL
BLEEDING
POSTMENOPAUSAL BLEEDING
It is bleeding from the genital tract occurring 6
months or more after cessation of menstruation
in a woman above the age of 40.
It is a serious symptom because in about 25%
of cases, it is due to a malignant lesion in the
genital tract
Prevalence
About 7 per 1000 postmenopausal women.
Aetiology
(A)
General Causes
(1) Oestrogen therapy (25%). Oestrogen given for
menopausal symptoms may lead to withdrawal
bleeding.
(2) hypertension.
(3)
blood diseases as leukemia.
(4)
anticoagulant therapy.
(B)Local Causes
Vulva. Malignant tumour, fissured leucoplakia,
urethral caruncle, and direct trauma.
Vagina. Malignant tumour, senile vaginitis,
trophic ulcer in prolapse, and retained foreign
body or pessary in the vagina.
Cervix. Malignant tumour, erosion and ulcers.
Uterus. Malignant tumour, senile endometritis,
tuberculous eiidometritis, fibroid
.
Diagnosis
A. History
Personal history
(a) Age: The commonest age incidence for carcinoma of
uterus is 55-70 years while that for carcinoma of the
vulva is 60-70 years.
(b) parity: some tumours are more common among
nulliparae e.g. endometrial and ovarian carcinoma.
Present history
Ask about the amount, character and duration of
bleeding, duration of menopause, and the presence of
other symptoms as pain and foul discharge, urinary and
gastrointestinal symptoms (malignant invasion of bladder
or bowel).
Past history
(a)Oestrogen therapy.
(b) diseases as diabetes mellitus,
B. General Examination
(I) Signs of anaemia.
(2) signs of bleeding disorders.
(3) presence of cachexia.
(4) examination of heart and chest for
secondaries.
(5) estimation of blood pressure
C Abdominal Examination
For a pelvi-abdominal mass and ascites
which is common with ovarian malignancy.
D.Pelvic Examination
To detect a local cause for bleeding. The
urethra and anal canal are excluded as
being the source of bleeding.
E. Special Investigations
Transvaginal sonography. It excludes the
presence of an ovarian tumour or a
lesion in the uterus as endometrial carcinoma.
2. Cervical smear. Taken in absence of bleeding
to detect the presence of malignant
cells which may come from the cervix,
endometrium, tubes, or ovaries.
1.
3.
Treatment
It is treatment of the cause.
If no cause can be detected the patient
should be followed up.
If bleeding recurs it is better to do
hysterectomy and bilateral salpingooophorectomy which may reveal a missed
early carcinoma of uterus or tube .
Thank you